Search

everythinglearnresearchcommunity

for

Search:↓

Zinc oxide nanoparticles made from Tridax procumbens leaves show strong antibacterial and anticancer effects.

Iontophoresis improves minoxidil delivery for alopecia treatment.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Cetuximab can cause unusual hair growth and hair loss.

Rituximab may cause skin issues, but baricitinib can help improve them.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Cetuximab can cause excessive eyelash growth.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

2% Minoxidil does not prevent hair loss during chemotherapy.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Sintilimab treatment caused hair loss but led to complete tumor remission.